Atlas Trials

Empagliflozin in Post-Transplantation Diabetes Mellitus

Clinical trial NCT03113110 · COMPLETED

Trial details

NCT number
NCT03113110
Sponsor
Medical University of Vienna
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Posttransplant Diabetes Mellitus
Start date
2017-01-15
Primary completion
2017-06-13
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.